Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Back to products list

Etodolac

Crystalline racemate, none

Therapeutic Area

Musculo-skeletal system

Status

Commercial

EU DMF readiness

US DMF readiness

CEP

Other documentation

Japanese DMF
Korean DMF
Canadian DMF
Brazilian DMF

CAS No.

41340-25-4

Reference Product

N/A

Drug description:

Etodolac belongs to anti-inflammatory drugs (NSAIDs).
Etodolac is indicated for acute or long term use in: osteoarthritis, rheumatoid arthritis. Etodolac is used to treat pain or inflammation caused by arthritis.
It is formulated as hard capsules, tablets in sustained release formulation, film-coated tablets for oral route of administration.

Mechanism of action:
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic actions. Etodolac is an inhibitor of the cyclooxygenase enzyme (COX) involved in prostaglandin synthesis. Etodolac is an selective inhibitor of COX-2.